ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 326,47
0,56%
Dow Jones
39 186,98
2,66%
DAX
21 293,53
0,45%
Brent Oil
67,175
0,19%
Bitcoin
93 122,96
-0,33%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Gilead Sciences Inc (GILD) Cours

Gilead Sciences Inc

Gilead Sciences Inc (GILD)

DMG Mori AG
DMG Mori AG
DMG Mori AG
DMG Mori AG
Guild Esports Plc
105,51
1,18
(1,13%)
Fermé 23 Avril 10:00PM
Retardé de 15 minutes
105,3777
-0,1323
(-0,13%)
Après les heures de négociation: 1:55AM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
105,3777
Prix Achat
103,15
Prix Vente
107,14
Volume échangé
7 530 094
104,78 Fourchette du Jour 106,44
62,07 Plage de 52 semaines 119,96
Cap du marché
131,232B
Clôture Veille
104,33
Ouverture
104,895
Dernière Transaction
4
@
106
Dernière heure de transaction
Volume financier
US$ 795 498 708
VWAP
105,6426
Volume moyen (3 m)
9 365 298
Actions en circulation
1 245 346 062
Rendement du Dividende
3.00%
Ratio Cours sur Bénéfices
273,77
Bénéfice par action (BPA)
0,39
Chiffre d'affairess
28,75B
Bénéfice net
480M

À propos de Gilead Sciences Inc

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmon... Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite acquisition and pending Forty-Seven acquisition boost Gilead's exposure to cell therapy and noncell therapy in oncology. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
www.gilead.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Gilead Sciences Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker GILD. Le dernier cours de clôture d'Gilead Sciences était de US$104,33. Au cours de la dernière année, les actions de Gilead Sciences ont été négociées dans une fourchette de prix de US$ 62,07 à US$ 119,96.

Gilead Sciences compte actuellement 1 245 346 062 actions en circulation. La capitalisation boursière d'Gilead Sciences est de US$129,93 milliard. Gilead Sciences a un ratio cours/bénéfice (ratio PE) de 273.77.

Flux d'options Gilead Sciences (GILD)

Voir le flux d'options complet

Flux global

Haussier

Prime nette

1M

Calls / Puts

833,33%

Ach. / Vent.

43,75%

OTM / ITM

27,27%

Sweeps Ratio

3,57%

GILD Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
16 Avril 2025
GILD (1,13%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
15 Avril 2025
GILD (1,13%)

Form PX14A6G - Notice of exempt solicitation submitted by non-management
Edgar (US Regulatory)
07 Avril 2025
GILD (1,13%)

Form ARS - Annual Report to Security Holders
Edgar (US Regulatory)
27 Mars 2025
GILD (1,13%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
20 Mars 2025
GILD (1,13%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
18 Mars 2025
GILD (1,13%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
17 Mars 2025
GILD (1,13%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-1.0223-0.960808270677106.4107.1103.097373931104.86666188CS
4-1.4523-1.35944959281106.83114.7597.329403570106.89954748CS
1210.367710.912219766395.01119.9693.819365298107.54713345CS
2619.767723.090409998885.61119.9685.618064110100.4273265CS
5238.447757.444643657666.93119.9662.07741509587.61687842CS
15641.597765.220602069663.78119.9657.165694899479.26889314CS
26025.637732.151617757779.74119.9656.56773167173.78270527CS

GILD - Frequently Asked Questions (FAQ)

What is the current Gilead Sciences share price?
The current share price of Gilead Sciences is US$ 105,3777
How many Gilead Sciences shares are in issue?
Gilead Sciences has 1 245 346 062 shares in issue
What is the market cap of Gilead Sciences?
The market capitalisation of Gilead Sciences is USD 129,93B
What is the 1 year trading range for Gilead Sciences share price?
Gilead Sciences has traded in the range of US$ 62,07 to US$ 119,96 during the past year
What is the PE ratio of Gilead Sciences?
The price to earnings ratio of Gilead Sciences is 273,77
What is the cash to sales ratio of Gilead Sciences?
The cash to sales ratio of Gilead Sciences is 4,57
What is the reporting currency for Gilead Sciences?
Gilead Sciences reports financial results in USD
What is the latest annual turnover for Gilead Sciences?
The latest annual turnover of Gilead Sciences is USD 28,75B
What is the latest annual profit for Gilead Sciences?
The latest annual profit of Gilead Sciences is USD 480M
What is the registered address of Gilead Sciences?
The registered address for Gilead Sciences is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Gilead Sciences website address?
The website address for Gilead Sciences is www.gilead.com
Which industry sector does Gilead Sciences operate in?
Gilead Sciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
GELSGelteq Ltd
US$ 2,87
(218,89%)
89,72M
SXTCChina SXT Pharmaceuticals Inc
US$ 2,08
(103,92%)
115,5M
TIVCTivic Health Systems Inc
US$ 7,12
(103,43%)
35,37M
WNWMeiwu Technology Company Ltd
US$ 2,43
(95,97%)
122,93M
MRINMarin Software Incorporated
US$ 0,8375
(70,92%)
2,83M
AIEVThunder Power Holdings Inc
US$ 0,014
(-70,53%)
1,47M
JYDJayud Global Logistics Ltd
US$ 0,1011
(-48,68%)
27,86M
OMHOhmyhome Ltd
US$ 2,21
(-38,61%)
599,73k
MKDWMKDWELL Tech Inc
US$ 0,2845
(-26,88%)
4,76M
PNBKPatriot National Bancorp Inc
US$ 3,07
(-23,82%)
361,41k
OCEAOcean Biomedical Inc
US$ 0,0385
(-3,75%)
366,68M
DMNDamon Inc
US$ 0,0037
(-11,90%)
310,74M
NVDANVIDIA Corporation
US$ 98,89
(2,04%)
240,99M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 7,40
(9,14%)
167,85M
TQQQProShares UltraPro QQQ
US$ 45,06
(7,64%)
130,1M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
GILD
Gilead Sciences
ASX
ALO
Alloggio
USOTC
CHGLF
China Glass (PK)
NASDAQ
VSGN
Vasogen
ASX
PRG
PRL Global
TG
3JO
Boart Longyear
TG
60A
Allegion
USOTC
CBUMY
China National Buildings... (PK)
USOTC
TGGRF
Taruga Minerals (PK)
TG
JAT
Japan Tobacco
TG
3EG
Endurance Gold
USOTC
CYBBF
Virgin Money UK (PK)
USOTC
VCTNY
Vection Technologies (PK)
USOTC
PEGHY
Pegasus Hava Tasimacilig... (PK)
USOTC
SUTNY
Sumitomo Mitsui (PK)
USOTC
SMNUF
Pt Sarana Menara Nusanta... (PK)
Delayed Upgrade Clock
ADVFN Logo
France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces